Allied Minds Hires Jeff Caputo To Help Guide Life Science Investments
29-Mar-2010
BOSTON – March 29, 2010 – Allied Minds, the premier early-stage technology investment firm focused on commercializing technologies from leading U.S. Universities and National Labs, announced today that Jeff Caputo has joined the firm.
Caputo will be responsible for identifying and evaluating investment opportunities in life science technologies as well as support management of life science subsidiary companies. He will be involved with developing go-to market strategies, product development, strategic planning, business development and the clinical approval process for existing life science portfolio companies. Caputo is also responsible for guiding these companies to exit by helping them achieve levels of commercial traction so they can either succeed as stand-alone entities or prepare for acquisition.
“Jeff’s background includes experience in the life sciences industry, early stage technology and product management,” said Chris Silva, Allied Minds’ CEO. “He comes to Allied Minds with a wealth of operating experiences and skills combining clinical knowledge, sales, marketing, strategy, and business development. All will prove instrumental as we continue to expand our portfolio of businesses.”
Caputo brings over 13 years of relevant experience in medical devices, early-stage high tech, and healthcare. Before joining Allied Minds, Jeff spent 8 years in sales and marketing management at Aspect Medical Systems, most recently as Manager of Market Development and Strategic Alliances. In this role he launched and managed products within surgery markets, managed global strategic alliances with industry leaders such as GE, Philips, and Draeger. Caputo also assisted in business development efforts to identify and evaluate synergistic technologies for acquisition. Prior, Jeff was a territory manager within the surgical sales team.
“I’m looking forward to joining the Allied Minds team and managing existing life science portfolio companies as well as sourcing and developing new life science opportunities. The Allied Minds team has a truly innovative approach to the traditional venture capital business model, focused on identifying and investing in promising early stage technologies out of US universities. I am excited to be a part of this unique organization.”
Caputo’s earlier experience includes sales and marketing roles within innovative internet start-up companies. He also provided direct patient care in emergency, cardiology, and neurology departments. Caputo earned an MBA from Boston College with a focus in Venture Capital and Entrepreneurial Management and holds a BA in Biology and Psychology from St. Olaf College.
About the Company
Allied Minds is more than a capital investment firm. Instead of managing funds, we build companies by fostering innovation. We are the premier seed organization for early-stage technology developed at renowned US Universities and National Labs. Allied Minds focuses on innovations with significant transformative possibilities. Our goal is to open new frontiers and revolutionize the way we live. Allied Minds is unique in its approach to managing investments. We are not a venture capital fund, rather, we are a holding company that creates subsidiary companies and supports them with capital, management, and shared services. The subsidiary is then free to focus on maturing the technology towards commercialization. We exit when the subsidiary and its underlying technology has achieved a level of commercial traction which demonstrates its ability to succeed as a stand-alone entity and provide our investors the maximum value for their investment. For further information please visit www.alliedminds.com.
Caputo will be responsible for identifying and evaluating investment opportunities in life science technologies as well as support management of life science subsidiary companies. He will be involved with developing go-to market strategies, product development, strategic planning, business development and the clinical approval process for existing life science portfolio companies. Caputo is also responsible for guiding these companies to exit by helping them achieve levels of commercial traction so they can either succeed as stand-alone entities or prepare for acquisition.
“Jeff’s background includes experience in the life sciences industry, early stage technology and product management,” said Chris Silva, Allied Minds’ CEO. “He comes to Allied Minds with a wealth of operating experiences and skills combining clinical knowledge, sales, marketing, strategy, and business development. All will prove instrumental as we continue to expand our portfolio of businesses.”
Caputo brings over 13 years of relevant experience in medical devices, early-stage high tech, and healthcare. Before joining Allied Minds, Jeff spent 8 years in sales and marketing management at Aspect Medical Systems, most recently as Manager of Market Development and Strategic Alliances. In this role he launched and managed products within surgery markets, managed global strategic alliances with industry leaders such as GE, Philips, and Draeger. Caputo also assisted in business development efforts to identify and evaluate synergistic technologies for acquisition. Prior, Jeff was a territory manager within the surgical sales team.
“I’m looking forward to joining the Allied Minds team and managing existing life science portfolio companies as well as sourcing and developing new life science opportunities. The Allied Minds team has a truly innovative approach to the traditional venture capital business model, focused on identifying and investing in promising early stage technologies out of US universities. I am excited to be a part of this unique organization.”
Caputo’s earlier experience includes sales and marketing roles within innovative internet start-up companies. He also provided direct patient care in emergency, cardiology, and neurology departments. Caputo earned an MBA from Boston College with a focus in Venture Capital and Entrepreneurial Management and holds a BA in Biology and Psychology from St. Olaf College.
About the Company
Allied Minds is more than a capital investment firm. Instead of managing funds, we build companies by fostering innovation. We are the premier seed organization for early-stage technology developed at renowned US Universities and National Labs. Allied Minds focuses on innovations with significant transformative possibilities. Our goal is to open new frontiers and revolutionize the way we live. Allied Minds is unique in its approach to managing investments. We are not a venture capital fund, rather, we are a holding company that creates subsidiary companies and supports them with capital, management, and shared services. The subsidiary is then free to focus on maturing the technology towards commercialization. We exit when the subsidiary and its underlying technology has achieved a level of commercial traction which demonstrates its ability to succeed as a stand-alone entity and provide our investors the maximum value for their investment. For further information please visit www.alliedminds.com.
